This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1998 Dec 12;352(9144):1932-3; author reply 1934.

doi: 10.1016/S0140-6736(05)60422-9.

The UK Prospective Diabetes Study

M Evans

PMID: 9863807
DOI: 10.1016/S0140-6736(05)60422-9

Comment

The UK Prospective Diabetes Study

M Evans. Lancet. 1998.

. 1998 Dec 12;352(9144):1932-3; author reply 1934.

doi: 10.1016/S0140-6736(05)60422-9.

Author

M Evans

PMID: 9863807
DOI: 10.1016/S0140-6736(05)60422-9

No abstract available

PubMed Disclaimer

Comment on

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
[No authors listed] [No authors listed] Lancet. 1998 Sep 12;352(9131):837-53. Lancet. 1998. PMID: 9742976 Clinical Trial.
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.
[No authors listed] [No authors listed] Lancet. 1998 Sep 12;352(9131):854-65. Lancet. 1998. PMID: 9742977 Clinical Trial.

Similar articles

The UK Prospective Diabetes Study.
Bailey CJ, Grant PJ. Bailey CJ, et al. Lancet. 1998 Dec 12;352(9144):1932; author reply 1934. doi: 10.1016/S0140-6736(98)00090-7. Lancet. 1998. PMID: 9863806 No abstract available.
The UK Prospective Diabetes Study.
Kerner W. Kerner W. Lancet. 1998 Dec 12;352(9144):1934. doi: 10.1016/S0140-6736(05)60427-8. Lancet. 1998. PMID: 9863811 No abstract available.
Mortality risk with sulphonylureas compared to metformin.
Holden SE, Currie CJ. Holden SE, et al. Diabetes Obes Metab. 2014 Oct;16(10):885-90. doi: 10.1111/dom.12280. Epub 2014 Mar 14. Diabetes Obes Metab. 2014. PMID: 24533964
Progressing From Metformin to Sulfonylureas or Meglitinides.
Grant JS, Graven LJ. Grant JS, et al. Workplace Health Saf. 2016 Sep;64(9):433-9. doi: 10.1177/2165079916644263. Workplace Health Saf. 2016. PMID: 27621259 Review.
Efficacy, effectiveness and safety of sulphonylurea-metformin combination therapy in patients with type 2 diabetes.
Hermann LS, Lindberg G, Lindblad U, Melander A. Hermann LS, et al. Diabetes Obes Metab. 2002 Sep;4(5):296-304. doi: 10.1046/j.1463-1326.2002.00189.x. Diabetes Obes Metab. 2002. PMID: 12190992 Review. No abstract available.

See all similar articles

Cited by

Metformin and mortality.
Lund SS. Lund SS. Diabetologia. 2013 Apr;56(4):937-8. doi: 10.1007/s00125-013-2843-y. Epub 2013 Feb 2. Diabetologia. 2013. PMID: 23377620 No abstract available.
Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes.
Wentholt IM, Kulik W, Michels RP, Hoekstra JB, DeVries JH. Wentholt IM, et al. Diabetologia. 2008 Jan;51(1):183-90. doi: 10.1007/s00125-007-0842-6. Epub 2007 Nov 10. Diabetologia. 2008. PMID: 17994218
Metabolic control and incidence of hypoglycaemia, hospitalisation and complications among Saudi patients with type 2 diabetes initiating second-line therapy: an analysis of the Saudi Arabia data from the DISCOVER Observational Study programme.
Al Rubeaan K, Banah F, Alruwaily FG, Sheshah E, Alnaqeb D, AlQahtani AM, Ewais D, Al Juhani N, Hassan AH, Youssef AM. Al Rubeaan K, et al. BMJ Open. 2023 Aug 30;13(8):e063586. doi: 10.1136/bmjopen-2022-063586. BMJ Open. 2023. PMID: 37648382 Free PMC article.
Nanomedicine-Based Strategies for Diabetes: Diagnostics, Monitoring, and Treatment.
Lemmerman LR, Das D, Higuita-Castro N, Mirmira RG, Gallego-Perez D. Lemmerman LR, et al. Trends Endocrinol Metab. 2020 Jun;31(6):448-458. doi: 10.1016/j.tem.2020.02.001. Epub 2020 Mar 4. Trends Endocrinol Metab. 2020. PMID: 32396845 Free PMC article. Review.
Conversation Maps and Diabetes Education Groups: An Evaluation at an Australian Rural Health Service.
Kewming S, D'Amore A, Mitchell EK. Kewming S, et al. Diabetes Spectr. 2016 Feb;29(1):32-6. doi: 10.2337/diaspect.29.1.32. Diabetes Spectr. 2016. PMID: 26912963 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information